Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Zai Lab Limited (NASDAQ: ZLAB).

Full DD Report for ZLAB

You must become a subscriber to view this report.


Recent News from (NASDAQ: ZLAB)

Zai Lab Reports Full Year 2017 Financial Results and Corporate Update
-- Zai Lab to Host Conference Call and Webcast Today at 8:30 a.m. ET-- SHANGHAI, China, May 02, 2018 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ:ZLAB), a Shanghai-based innovative biopharmaceutical company, today will provide an overview of financial results for the year ended Decemb...
Source: GlobeNewswire
Date: May, 02 2018 07:00
Zai Lab in-licenses Entasis Therapeutics' broad-spectrum antibiotic in Asia-Pacific; shares up 3%
Shanghai-based Zai Lab Limited ( ZLAB +2.9% ) inks an exclusive license agreement with privately held Entasis Therapeutics for the rights to broad-spectrum intravenous antibiotic ETX2514 in the Asia-Pacific region. More news on: Zai Lab Ltd., AstraZeneca Group plc, Healthcare stocks news...
Source: SeekingAlpha
Date: April, 25 2018 11:05
Entasis Therapeutics and Zai Lab Announce Exclusive License Agreement in Asia-Pacific and Global Strategic Development Collaboration for ETX2514
WALTHAM, Mass. and SHANGHAI, China, April 25, 2018 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc., a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, and Zai Lab Limited (NASDAQ:ZLAB), a Shanghai-based innovative biop...
Source: GlobeNewswire
Date: April, 25 2018 08:00
Zai Lab Limited Announces Presentations at May Investor Conferences
SHANGHAI, China, April 24, 2018 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ:ZLAB), a Shanghai-based innovative biopharmaceutical company, today announced that members of the senior management team will participate at two upcoming investor conferences. Details of the presentations are as fol...
Source: GlobeNewswire
Date: April, 24 2018 16:05
Zai Lab Limited to Announce Full Year 2017 Financial Results
SHANGHAI, China, April 24, 2018 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ:ZLAB), a Shanghai-based innovative biopharmaceutical company, today announced that it will host a conference call and webcast on Wednesday, May 2 nd , 2018 at 8:30am ET to discuss financial results for the full year...
Source: GlobeNewswire
Date: April, 24 2018 08:30
Paratek: A Review Of Progress And Preview Of 2018
Paratek Pharmaceuticals ( PRTK ) is a biopharmaceutical company making steady progress towards approval of its novel tetracycline antibiotic, omadacycline. Omadacycline produced impressive results in three phase 3 studies, the results of which, coupled with other progress, can no longer be see...
Source: SeekingAlpha
Date: March, 21 2018 15:56
Stocks To Watch: Wake-Up Call For The IPO Market
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. The sleepy IPO market could get a jolt at the end of the week as Dropbox (DBX) is e...
Source: SeekingAlpha
Date: March, 17 2018 08:47
Zai Lab A Short Ahead Of Lockup Expiration
March 19, 2018 concludes the 180-day lockup period on Zai Lab Ltd. ( ZLAB ). When the lockup period ends for Zai Lab, its pre-IPO shareholders and insiders will be able to sell large blocks of previously-restricted stock for the first time. This group of shareholders includes eight individua...
Source: SeekingAlpha
Date: March, 14 2018 12:15
Zai Lab Limited Appoints Billy Cho as Chief Financial Officer
SHANGHAI, China, March 05, 2018 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ:ZLAB), a Shanghai-based innovative biopharmaceutical company, today announced the appointment of Billy Cho as Chief Financial Officer. Mr. Cho joins from Citigroup where he was the Managing Director and Head of Asia...
Source: GlobeNewswire
Date: March, 05 2018 07:00
Zai Lab Limited to present at the Leerink Partners 7th Annual Global Healthcare Conference
SHANGHAI, China, Feb. 07, 2018 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ:ZLAB), a Shanghai-based innovative biopharmaceutical company, today announced that Chief Executive Officer, Samantha Du, will present at the Leerink Partners 7 th Annual Global Healthcare Conference.  Details...
Source: GlobeNewswire
Date: February, 07 2018 16:05

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-05-1721.1020.6121.1020.261251,850

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-209,07817,78551.0430Short
2018-08-173,25810,11932.1969Cover
2018-08-165,5468,27267.0455Short
2018-08-153,21512,06526.6473Cover
2018-08-145,75014,55939.4945Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on ZLAB.


About Zai Lab Limited (NASDAQ: ZLAB)

Logo for Zai Lab Limited (NASDAQ: ZLAB)

Not available

 

Contact Information

     

     

    Current Share Structure

       


      Recent Filings from (NASDAQ: ZLAB)

      Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
      Filing Type: 6-KFiling Source: edgar
      Filing Date: May, 02 2018
      Annual and transition report of foreign private issuers under sections 13 or 15(d)
      Filing Type: 20-FFiling Source: edgar
      Filing Date: April, 30 2018
      Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
      Filing Type: 6-KFiling Source: edgar
      Filing Date: April, 25 2018
      Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
      Filing Type: 6-KFiling Source: edgar
      Filing Date: April, 24 2018
      Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
      Filing Type: 6-KFiling Source: edgar
      Filing Date: March, 05 2018
      Statement of beneficial ownership of common stock by certain persons
      Filing Type: SC 13GFiling Source: edgar
      Filing Date: February, 26 2018
      Statement of beneficial ownership of common stock by certain persons
      Filing Type: SC 13GFiling Source: edgar
      Filing Date: February, 14 2018
      Statement of beneficial ownership of common stock by certain persons
      Filing Type: SC 13GFiling Source: edgar
      Filing Date: February, 14 2018
      Statement of beneficial ownership of common stock by certain persons
      Filing Type: SC 13GFiling Source: edgar
      Filing Date: February, 14 2018
      Statement of beneficial ownership of common stock by certain persons
      Filing Type: SC 13GFiling Source: edgar
      Filing Date: February, 13 2018

       

       


      Daily Technical Chart for (NASDAQ: ZLAB)

      Daily Technical Chart for (NASDAQ: ZLAB)


      Stay tuned for daily updates and more on (NASDAQ: ZLAB)

      It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

      More to come on (NASDAQ: ZLAB)

      Do your DD and if you choose, be ready to go!


       

      The Research: All source information contained in this email is from the public sources mentioned below.

       

       
       

      Thank you

      DD Report
      @DDReports

       

       


      Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in ZLAB is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of ZLAB and does not buy, sell, or trade any shares of ZLAB. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/